- Study finds more number of younger women with stage two and three breast cancer
- Spreading cancer to other sites than the primary site also high in younger aged women
- The research reveals poorer outcome of treatments for younger women affected by breast cancer
- Researchers recommend better public health system to reach out to the younger women.
Breast cancer is the most common cancer among women, and around 5.6 percent patients with breast cancer are women less than 40 years. With the effective awareness among the public, it has been successfully diagnosed in early stages in many. But, it still remains dormant in some and by the time it got detected, the cancer might have taken an aggressive manner.
A new research conducted by Deepti Sharma and Garima Singh, Department of Radiation Oncology, VMMC and Safdarjung Hospital, New Delhi, substantiates that breast cancer among younger women (less than 40 years) found to be yielding poorer clinical outcome when compared to the treatment of elder cancer patients.
As per the research, out of 372 patients who took treatment at the hospital in Delhi, 133 breast cancer patients were women less than 40 years. Out of this, 125 young cancer patients were diagnosed with the second and third stage of the disease.
In the same manner, the metastasis (development of secondary growth at a distance from the primary site of cancer) was found to be higher in less than 40 years women with breast cancer. Brain Metastasis was prevalent in 57.69 percent patients in the less than 40 years category while the same was 32.14 percent, in above-40-years category.
The study also found out that tumor relapse, the appearance of the tumor again, was also higher in the breast cancer patients of less than 40 years category.
The research throws light upon the need to address prognostic system that can increase the diagnosis and treatment of breast cancer in younger women. Despite the wide campaigns for breast cancer, many younger women are detected with stage 3 cancer which results in the poorer clinical outcome. With the progression of cancer, the treatments fetch less results leading to the poorer clinical outcome, as indicated by the researchers.
The study was published in the latest issue of South Asian Journal of Cancer.